Palantir’s Execution Has Been ‘Stunning.’ Why It Isn’t Time to Buy the Stock.
Palantir’s track record has been called “stunning,” but a recent piece from Barron suggests that now may not be the ideal moment to invest. The article tackles how the company’s success and a wary outlook can coexist.
1 day ago
1 min read